Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesImproved endothelial function after endothelin receptor blockade in patients with systemic sclerosis
Arthritis & Rheumatism, 06/04/09
Cardillo C et al. – Endothelin 1 (ET-1)-dependent vasoconstrictor tone is increased predominantly in the subgroup of systemic sclerosis (SSc) patients with diffuse cutaneous SSc (dcSSc), in whom acute blockade of ETA receptors was able to improve impaired endothelium-dependent vasodilator function, suggesting a novel vasculoprotective effects of ETA receptor antagonism.
Methods- An investigation of whether increased activity of ET-1 system plays a role in the occurrence of endothelial dysfunction in pts with SSc
- 12 pts with SSc: 6 with dcSSc, 6 with limited cutaneous SSc (lcSSc)
- Forearm blood flow responses to graded doses of acetylcholine (ACh) and sodium nitroprusside (SNP) were assessed by plethysmography, during infusion of saline and following selective blockade of ETA receptors with BQ-123
- During saline infusion, the vasodilator response to ACh was blunted in pts with SSc vs healthy controls
- Whereas response to SNP was not different between groups
- Vasodilator effect of ETA receptor antagonism was higher in pts, indicating enhanced ET-1-mediated vasoconstriction in SSc
- In pts, ETA receptor blockade resulted in a potentiation of the vasodilator response to Ach, but did not affect the response to SNP
- Both the vasodilator effect of ETA receptor antagonism and the improvement in the responsiveness to ACh following BQ-123 infusion were higher in pts with dcSSc vs lcSSc
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09
Treatment of adult inflammatory myositis with rituximab: An emerging therapy for refractory patients
Journal of Clinical Rheumatology (JCR), 10/08/09
Is pulmonary arterial hypertension really a late complication of systemic sclerosis
Chest, 10/12/09
Sponsor
Article Search
Sponsor